Objective: Mouse embryonic stem cells (mESC) have demonstrated the potential to restore the infarcted myocardium following an acute myocardial infarction (AMI). Although the underlying mechanism remains controversial, MRI has provided reliable in vivo assessment of functional recovery following cell transplantation. Multi-modality comparison of the restorative effects of mESC and mouse embryonic fibroblasts (mEF) was performed to validate MRI data and provide mechanistic insight.
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Experimental animals. Animal care and interventions were provided in accordance with the Laboratory Animal Welfare Act, the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, publication 78- 23, revised 1978) . Immunotolerant SCID-beige female mice (8) (9) (10) (11) (12) weeks, Charles River, Wilmington, MA) were anesthetized in an isoflorane inhalational chamber and endotracheally intubated with a 20 gauge angiocath (Ethicon Endo-Surgery, Inc.
Cincinnati, OH). Ventilation was maintained with a Harvard rodent ventilator. Myocardial infarction was created by ligation of the mid-left anterior descending (LAD) artery through a left thoracotomy. The mice were randomized into three groups: 1) LAD ligation with normal saline (NS) injection (n=10), 2) LAD ligation with mESC injection (n=25), or 3) LAD ligation with mEF injection (n=20). The infarct region was injected with 25mL using a Hamilton syringe containing 250,000 mESC, mEF, or NS. Cell suspensions contained rhodamine beads (6 x 10 5 ) to ensure injection accuracy. Following chest tube placement, the chest was closed in 2 layers with 5-0 vicryl.
In vivo MRI. One week after transplantation, cardiac MRI was obtained using a Unity Inova console (Varian, Inc., Palo Alto, CA) controlling a 4.7T, 15cm horizontal bore magnet (Oxford Instruments, Ltd., Oxford, UK) with GE Techron Gradients (12G/cm) and a volume coil with a diameter of 3.5cm (Varian, Inc., Palo Alto, CA). The ECG gating was optimized using 2 subcutaneous precordial leads with respiratory motion and body temperature monitors (SA Instruments, Inc., Stony Brook, NY). LV function was evaluated using ECG-triggered cine sequence (TE 2.8-ms, TR 160-ms, FA 60°, FOV 3.0cm2, matrix 128×128, slice gap 0-mm, slice thickness 1.0-mm, 8 NEX, and 12 cardiac phases). The imaging plane was localized using double-oblique acquisition.
The data were analyzed using MR Vision software (Winchester, MA). LV ejection fraction (LVEF), end-diastolic (LVED), and end-systolic (LVES) volumes were calculated by tracing the endocardial borders in end-systole and -diastole.
Pressure-volume (PV) loop analysis. One week after transplantation, ventricular performance was assessed by PV loop analysis using a 1.4 F conductance catheter (Millar Instruments, Houston, TX) prior to euthanasia. The closed chest technique was utilized which consisted of a midline neck incision to access the left external jugular vein with PE10 tubing (Intramedic-Becton Dickinson). The right carotid was cannulated with the Millar catheter and advanced through the aortic valve into the LV. The PV relations were measured at baseline and during inferior vena cava occlusion. The measurements of segmental conductance were recorded which allowed extrapolation of the left ventricular volume. When coupled with pressure, the generation of ventricular PV relationships allowed precise hemodynamic characterization of ventricular systolic and diastolic function and loading conditions. 12 These data were analyzed using PVAN 3.4 Software (Millar Instruments, Inc.) and Chart/Scope Software (AD Instruments, Inc.).
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In vIvo MRI OF mESC-MEDIATED MYOCARDIAL RESTORATION | 23 In vitro firefly luciferase (fluc) assay. On the day of operation, parallel sets of cells from the same plates as the injected cells were trypsinized, resuspended in PBS and divided into a 6-well plate in different concentrations. After administration of D-luciferin (Xenogen, California, USA, 4.5ug/mL), peak signal expressed as photons per second per centimeter square per steridian (p/s/cm 2 /sr) was measured using a charged coupled device (CCD) camera (Xenogen, California, USA).
In vivo optical bioluminescence imaging (BLI). Optical BLI was performed using 8 x 5 minute acquisition scans on a CCD camera (IVIS 50, Xenogen, California, USA). Recipient mice were anesthetized and placed in the imaging chamber. After acquisition of a baseline image, mice were intraperitoneally injected with D-luciferin (Xenogen, USA, 400 mg/kg body weight). Peak signal (p/s/cm 2 /sr) from a fixed region of interest (ROI) was evaluated using the Living Image 2.50 software (Xenogen, USA).
Ex vivo TaqMan PCR (TM-PCR) for cell survival and expression of genes of interest.
Since the transplanted cells were derived from male mice and were transplanted into female recipients, the surviving mESC in the explanted hearts could be quantified using TM-PCR to track the SRY locus found on the Y chromosome. Whole explanted hearts were minced and homogenized in DNAzol (Invitrogen, Carlsbad, CA). RNA was extracted from the mice myocardium after treatment with TRIzol reagent (Invitrogen, Carlsbad, CA). Taqman PCR was performed using SuperScript II RT-PCR kit (Invitrogen, Carlsbad, CA). To assess the expression of several genes of interest, relative quantitation of mouse primers was performed for: matrix metalloproteinase (MMP)-1β, -2, -9, -14, tumor necrosis factor (TNF)-α, vascular endothelial growth factor (VEGF)-A, procollagen-2α1, transforming growth factor (TGF)-β, angiotensin converting enzyme (ACE), insulin-like growth factor (IGF) 1, Flk-1, and NFkβ-1 (Applied Biosystems, Foster City, CA). The fluorogenic probes contained a 5'-FAM report dye and 3'-BHQ1 quencher dye.
TaqMan 18S Ribosomal RNA (Applied Biosystems, Foster City, CA) was used as control gene.
RT-PCR reactions were conducted in iCylcer IQ Real-Time Detection Systems (Bio-Rad, Hercules, CA).
Histological analysis.
Hearts were flushed with NS and subsequently placed in 2% paraformaldehyde for 2 hours at room temperature followed by 12-24 hours in 30% sucrose at 4°C. 
Statistical analysis. Descriptive statistics included mean and standard error. Comparison
between groups was performed using students' t-test for independent and normally distributed data variables using SPSS 11.0. For comparison between multiple groups, ANOVA with Bonferroni correction was utilized. Significance was assumed when p<0.05. Table 1 . These findings challenge the current notion that myocardial function is improved irrespective of cell type. 16, 17 The preservation of cardiac performance following cell transplantation cannot be attributed merely to the physical scaffolding effect but also must arise from the biological properties of the transplanted cells. During myocardial ischemia, the ischemic region develops diastolic and subsequent systolic abnormality. 18 Studies have confirmed the Frank-Starling relationship in which contractile function is preserved with reduction in ventricular volume. 19 In fact, our PV-loop results indicate a reduction in ventricular volume in the mESC group. This reduction involves complex yet fundamental biological processes. First, the prolonged survival kinetics of mESC can offer a longer lasting scaffolding effect, which may help to explain both the reduction in pathological remodeling and sustained restoration. More importantly, however, the persistence of viable mESC generates biologically active stimuli to salvage the injured myocytes. Thus, this enhanced survival of mESC enables a second potential mechanistic explanation for in vivo MRI findings of myocardial restoration: paracrine effect. The results from ex vivo TM-PCR demonstrate that the potential anti-apoptotic cytokine, TNF-a, was significantly upregulated in the mESC-treated group. TNF-α has been shown to have negative inotropic effects, to induce resistance to hypoxic stress in cardiomyocytes, and to play a role in the recruitment of stem cells. [20] [21] [22] [23] It must be stated, however, that the increased TNF-a expression could also be attributable to a greater mass effect of mESC, with a subsequent greater endoge-32 | PART I: EMBRYONIC STEM CELLS -CHAPTER 2 nous inflammatory reaction, a greater mESC-induced monocyte influx, or teratoma formation leading to endogenous TNF-a production. In addition, the observed up-regulation of VEGF-A in this study may promote angiogenesis to attenuate the ischemic insult to recover the injured cardiomyocytes. Finally, non-significant trends towards down-regulation of matrix metalloproteinase-1 (MMP-1) and procollagen 2α-1 have also been detected, which may contribute to decreased cardiac matrix remodeling in failing hearts. 24 Surprisingly, we did not observe upregulation of MMP-2 and -9. This may have been because the absence of T-cells in the SCID mice, on which MMP-2 and -9 expressions have been shown to depend. 25 Taken together, these TM-PCR results suggest that multiple mechanisms underlie the restoration by mESC.
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The pluripotency of mESC may lead to regeneration of cardiac tissue after cardiomyogenic differentiation. 26 In order to contract synchronously with host cardiomyocytes, newly formed mESC-derived cardiomyocytes must undergo electromechanical coupling through the formation of gap junctions in vivo with the host myocardium. 26, 27 This study provides possible evidence that donor mESC are capable of engrafting within the host myocardium and differentiating into cardiomyocytes. While these findings are encouraging, it must be noted that this was a low-frequency event, making it less likely that the observed functional improvement can be attributed to robust cardiac regeneration by mESC-derived cardiomyocytes.
There are several limitations of this study. First of all, in order to investigate the acute effect of cell survival, we chose to compare fast-growing, undifferentiated mESC and less active mEF.
This gave us the opportunity to study the relationship between cardiac function and cell survival in a relatively short period of one week. However, it must be stated that eventual teratoma formation, as suggested by our BLI findings on POD 14 and consistent with the literature 13, 15, 28 , would likely hamper long term restoration of cardiac function. Secondly, this study does not provide insight in acute post-operative infarct size, which may have been dependent upon cell type. All operations, however, were conducted by the same experienced micro-surgeon that was blinded to the study. Moreover, after one week, all operated groups had a significant compromised LVEF on MRI, which lead to the assumption that infarct size had been comparable in all study groups. Third, we focused on validating the most important MRI data, namely LVED and LVES. Wall thickness, which could have correlated with cell survival, was not measured since we did not anticipate regenerative changes in the immediate period after AMI. Other studies are currently underway to address the regenerative changes by measuring wall thickness.
In conclusion, this is the first study to provide a fundamental functional and biological evaluation of in vivo MRI in mESC therapy. This study has shown that mESC are superior to mEF in restoring cardiac function in the immediate post-AMI period. A very fundamental notion that
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In vIvo MRI OF mESC-MEDIATED MYOCARDIAL RESTORATION | 33 the cells must at the very least survive to restore the myocardium is confirmed as the enhanced survival of mESC is attributed as one of the key factors in myocardial restoration. Improved survival of transplanted cells may not only offer a physical scaffolding mechanism but, more importantly, biological support by generating sustained paracrine effects after injury. We have also observed that mESC retain the ability to differentiate into cardiomyocytes, albeit at low frequency. Unfortunately, although the pluripotency and robust proliferation are among the major advantages of embryonic stem cells, these characteristics also contribute to teratoma formation 13, 15 , which, for the present, prevents clinical translation. Further research regarding directed differentiation of mESC into cardiomyocytes may lead to a safe regenerative therapy for myocardial disease in the future. 
